Public SEC Form D records
Biotech Series B Form D filings - May 2026
This page lists the 13 matching Form D filings FormDFlow has indexed and tagged from public SEC EDGAR records for Biotech-tagged issuers at a FormDFlow-inferred Series B stage in May 2026 - a filtered subset, not every matching Form D filed, and not a ranked, curated, or recommended selection. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.
- Filings
- 13
- Issuers
- 13
- Combined disclosed
- $274.9M
Directory links
Filing records
13 crawlable filing links in this facet.
- Kayak Therapeutics, Inc.May 27, 2026 / Reg D 506(b) / TX$25.0M
- Neela Therapeutics, Inc.May 26, 2026 / Reg D 506(b) / MA$21.5M
- AFFINITY BIOSENSORS LLCMay 21, 2026 / Reg D 506(b) / CA$18.0M
- Lantern Pharma Inc.May 21, 2026 / Reg D 506(b) / TX$0
- Verismo Therapeutics, Inc.May 20, 2026 / Reg D 506(b) / PA$28.0M
- CNS Pharmaceuticals, Inc.May 19, 2026 / Reg D 506(b) / TX$22.5M
- Shape Memory Medical Inc.May 18, 2026 / Reg D 506(b) / CA$17.0M
- ThinkBio.Ai, IncMay 18, 2026 / Reg D 506(b) / CA$20.0M
- Veradermics, IncMay 15, 2026 / Reg D 506(b) / CT$30.0M
- Athos Therapeutics, Inc.May 15, 2026 / Reg D 506(b) / CA$20.0M
- Solius Labs, Inc.May 14, 2026 / Reg D 506(b) / WA$17.9M
- Cue Biopharma, Inc.May 14, 2026 / Reg D 506(b) / MA$30.0M
- Pillar Therapeutics, Inc.May 13, 2026 / Reg D 506(b) / MA$25.0M